AI-10-49 25mg 25mg | Purity Not Available
Adooq Bioscience
AI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF??-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM,
More Information Supplier PageAI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF??-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM,
More Information Supplier PageAI-10-49 is a protein-protein interaction inhibitor that selectively binds to CBF??-SMMHC and disrupts its binding to RUNX1 with a FRET IC50 of 0.26 uM,
More Information Supplier PagePexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
More Information Supplier PagePexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
More Information Supplier PagePexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
More Information Supplier PagePLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively.
More Information Supplier PagePLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively.
More Information Supplier PagePLX647 is a highly specific dual FMS/KIT kinase inhibitor with IC50 of 28/16 nM respectively.
More Information Supplier PageSU6656 is a selective inhibitor of Src kinases, Including Src, Yes, Lyn, and Fyn (IC50 = 280, 20, 130, 170 nM, respectively).
More Information Supplier PageWHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
More Information Supplier Page